Premium
Letter: limitations of studies to evaluate the significance of anti‐tumour necrosis factor serum levels in Crohn's disease – authors' reply
Author(s) -
Levesque B. G.,
Feagan B. G.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12817
Subject(s) - medicine , infliximab , trough (economics) , crohn's disease , trough level , disease , trough concentration , pharmacokinetics , population , pharmacodynamics , gastroenterology , transplantation , environmental health , economics , macroeconomics , tacrolimus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom